The global burden of metabolic disease: Data from 2000 to 2019Nicholas Chew, Mark Muthiah, Cheng Han Ng et al.|Cell Metabolism|2023Cited by 777
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 IndividualsKai En Chan, Cheng Han Ng, Tiffany Jia Ling Koh et al.|The Journal of Clinical Endocrinology & Metabolism|2022Cited by 306
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 StudiesKai En Chan, Mark Muthiah, Elden Yen Hng Ong et al.|Clinical Gastroenterology and Hepatology|2023Cited by 126
Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individualsAnsel Shao Pin Tang, Cheng Han Ng, Kai En Chan et al.|Clinical and Molecular Hepatology|2022Cited by 97
The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regionsRachel Sze Jen Goh, Duk‐Woo Park, Mark Muthiah et al.|The Lancet Regional Health - Western Pacific|2024Cited by 75